Combination therapy with TNF inhibitors plus biologics targeting type 2 inflammatory conditions in patients with rheumatoid arthritis: a case series
This case series demonstrates that adding a second biologic agent to target type 2 inflammatory conditions in RA patients on TNFi did not increase incident bacterial infections and may decrease corticosteroid use.
Authors
- Anthony J. Ocon (ORCID: https://orcid.org/0000-0003-2903-5429)
- Allison Ramsey (ORCID: https://orcid.org/0000-0002-1691-4232)
- Azza Abdalla
- Ranjini Vengilote
- S Shahzad Mustafa
Institutions
- University of Rochester Medical Center (US)
- Unity Health System (US)
Publication Details
- Journal
- Rheumatology Advances in Practice
- Published
- 2025-12-25
- DOI
- https://doi.org/10.1093/rap/rkaf150
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00